Chemotherapeutic Interventions Against Tuberculosis

Chemotherapeutic Interventions Against Tuberculosis

Tuberculosis is the second leading cause of infectious deaths globally. Many effective conventional antimycobacterial drugs have been available, however, emergence of multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) has overshadowed the effectiveness of...

Full description

Bibliographic Details
Main Authors:	Neeraj Shakya, Gaurav Garg, Babita Agrawal, Rakesh Kumar
Format:	Article
Language:	English
Published:	MDPI AG 2012-06-01
Series:	Pharmaceuticals
Subjects:	tuberculosis chemotherapy mycobacterium drug-resistant tuberculosis emerging TB drugs
Online Access:	http://www.mdpi.com/1424-8247/5/7/690

Similar Items

Characterization of drug susceptibility of Mycobacterium tuberculosis isolated from new cases of tuberculosis concurrent with HIV infection
by: G. V. Panov, et al.
Published: (2015-02-01)

Efficiency of various methods of injection of antituberculosis agents in young patients with destructive pulmonary tuberculosis
by: I. A. Morozov, et al.
Published: (2016-09-01)

Extensively drug-resistant tuberculosis: a case report and literature review
by: João Alves de Araújo-Filho, et al.

Contribution to the research on drug resistant Mycobacterium tuberculosis
by: Stoffels, Karolien
Published: (2014)

Drug resistance of Mycobacterium tuberculosis isolates from tuberculosis lymphadenitis patients in Ethiopia
by: Fantahun Biadglegne, et al.
Published: (2014-01-01)

Pattern of drug resistance of Mycobacterium tuberculosis clinical isolates to first-line antituberculosis drugs in pulmonary cases
by: Deepika Kalo, et al.
Published: (2015-01-01)

Multidrug-Resistant Tuberculosis, People’s Republic of China, 2007–2009
by: Guang Xue He, et al.
Published: (2011-10-01)

Drug resistance among extrapulmonary TB patients: Six years experience from a supranational reference laboratory
by: Azger Dusthackeer, et al.
Published: (2015-01-01)

Hospital Control and Multidrug-Resistant Pulmonary Tuberculosis in Female Patients, Lima, Peru
by: Field F. Willingham, et al.
Published: (2001-02-01)

Drug Resistance Characteristics of Mycobacterium tuberculosis Isolates From Patients With Tuberculosis to 12 Antituberculous Drugs in China
by: Xiaocui Wu, et al.
Published: (2019-11-01)

Predominance of Beijing genotype in extensively drug resistant Mycobacterium tuberculosis isolates from a tertiary care hospital in New Delhi, India
by: Jyoti Arora, et al.
Published: (2013-01-01)

Drug resistance profiles and trends in drug-resistant tuberculosis at a major hospital in Guizhou Province of China
by: Lan YB, et al.
Published: (2019-01-01)

Overview of drug-resistant tuberculosis worldwide
by: Ali A Velayati, et al.
Published: (2016-01-01)

Machine Learning Predicts Accurately Mycobacterium tuberculosis Drug Resistance From Whole Genome Sequencing Data
by: Wouter Deelder, et al.
Published: (2019-09-01)

The detection of drug resistant mutations in mycobacterium tuberculosis strains using anyplex MTB/NTM/MDR-TB plus assay in Limpopo Province
by: Mpanyane, Disego Mmatau
Published: (2017)

Line-probe assay and molecular typing reveal a potential drug resistant clone of Mycobacterium tuberculosis in Ethiopia
by: Shiferaw Bekele, et al.
Published: (2018-12-01)

Emergence and Spread of Extensively and Totally Drug-Resistant Tuberculosis, South Africa
by: Marisa Klopper, et al.
Published: (2013-03-01)

Investigating permeation of anti-mycobacterial agents in Mycobacterium tuberculosis and M. tuberculosis-infected macrophages in vitro as a model for early stage tuberculosis drug discovery
by: Mabhula, Amanda N
Published: (2021)

TARGETING DORMANT BACILLI TO FIGHT TUBERCULOSIS
by: Lanfranco Fattorini, et al.
Published: (2013-11-01)

Preliminary Favorable Outcome for Medically and Surgically Managed Extensively Drug-Resistant Tuberculosis, France, 2009–2014
by: Benoît Henry, et al.
Published: (2016-03-01)

Multidrug-Resistant Tuberculosis in Europe, 2010–2011
by: Gunar Günther, et al.
Published: (2015-03-01)

Prevalence of Antibiotic Resistance to Isonicotinylhydrazide and Rifampicin in Culture Positive Pulmonary Tuberculosis Patients from 2014 to 2016 in Zahedan City, Iran
by: Seyed Mohammad Hashemi Shahri, et al.
Published: (2019-06-01)

Optimasi Suhu Annealing Tiga Regio Berbeda Isolat Multidrug Resistance Mycobacterium Tuberculosis dengan Metode Multiplex Polymerase Chain Reaction (ANNEALING TEMPERATURE OPTIMIZATION ON THREE DIFFERENT REGIONS OF MYCOBACTERIUM TUBERCULOSIS MULTIDRUG RESI
by: Indra Juana Adikara, et al.
Published: (2017-01-01)

In vitro antimicrobial efficacy of a fixed-dose combination of RHZE against M. tuberculosis
by: Vanessa Albertina Agertt, et al.

Multidrug- and Extensively Drug-Resistant Mycobacterium tuberculosis Beijing Clades, Ukraine, 2015
by: Matthias Merker, et al.
Published: (2020-03-01)

Genotypic and phenotypic characterization of Mycobacterium tuberculosis resistance against fluoroquinolones in the northeast of Iran
by: Mahdieh Sayadi, et al.
Published: (2020-06-01)

Emergence of Increased Resistance and Extensively Drug-Resistant Tuberculosis Despite Treatment Adherence, South Africa
by: Alistair D. Calver, et al.
Published: (2010-02-01)

The spectrum of primary drug resistance of Mycobacterium tuberculosis in patients with tuberculosis in relation to human immunodeficiency virus status
by: V N Zimina, et al.
Published: (2017-11-01)

Multidrug-resistant tuberculosis: case reports study in a central state of Brazil
by: João Alves de Araújo-Filho, et al.

Amplification of drug resistance against the background of inadequate chemotherapy for pulmonary tuberculosis
by: I. A. Burmistrova, et al.
Published: (2019-09-01)

EFFECT OF SOME MEDICINAL PLANTS ON GROWTH OF MYCOBACTERIUM TUBERCULOSIS, MULTI DRUG RESISTANT MYCOBACTERIUM TUBERCULOSIS AND MYCOBACTERIUM OTHER THAN TUBERCULOSIS
by: Prashant Shukla, et al.
Published: (2013-12-01)

Individualised treatment for multidrug‐resistant tuberculosis in New South Wales, Australia
by: Vicky Chang, et al.
Published: (2021-10-01)

Tuberculosis: Past, present and future of the treatment and drug discovery research
by: Ameya D. Bendre, et al.
Published: (2021-01-01)

Do we need a new Fleming époque: The nightmare of drug-resistant tuberculosis
by: Giovanni Sotgiu, et al.
Published: (2013-01-01)

Determining Mycobacterium tuberculosis Drug Resistance and Risk Factors for Multidrug-Resistant Tuberculosis in Sputum Smear-Positive Tuberculosis Outpatients in Anhui Province, China, 2015–2016
by: Yao S, et al.
Published: (2020-04-01)

Genotypic and phenotypic heterogeneity of Mycobacterium tuberculosis recovered from patients with pulmonary disease involving drug-resistant tuberculosis
by: Axcell, Amanda
Published: (2014)

Mechanism of Action, Resistance, Synergism, and Clinical Implications of Delamanid Against Multidrug-Resistant Mycobacterium tuberculosis
by: Saeed Khoshnood, et al.
Published: (2021-10-01)

Multidrug and extensively drug-resistant tuberculosis management: Evidences and controversies
by: R Prasad
Published: (2012-01-01)

Patterns of drug resistance in cases of smear positive pulmonary tuberculosis in Giza and Cairo governorates
by: K. Aid Sobhy, et al.
Published: (2012-10-01)

Molecular characterization of pyrazinamide resistance in Mycobacterium tuberculosis
by: Ko, Wai-ting, et al.
Published: (2014)